Features Partner Sites Information LinkXpress
Sign In

Varian Acquires MRI Magnet Manufacturer

By HospiMedica staff writers
Posted on 18 Oct 2004
Print article
Varian, Inc. (Palo Alto, CA, USA) has agreed to acquire Magnex Scientific, Ltd. (Oxford, UK) for U.S.$32 million. Magnex designs and manufactures magnetic resonance imaging (MRI) magnets. It is also an international supplier of vertical high-resolution nuclear MR (NMR) magnets, superconductor magnets for Fourier transform mass spectroscopy (FTMS), and MR microscopy gradients.

In connection with the acquisition, Varian also plans to rationalize its field support administration in the United Kingdom, which is expected to result in charges to earnings totaling about $2.0 million. Magnex will be operated as a wholly owned subsidiary of Varian. Varian will continue its longtime partnership with Oxford Instruments Superconductivity, which supplies high-resolution magnets for the company's NMR spectrometer systems, and Magnex will continue to offer its complete range of MRI, NMR, and FTMS magnets to its existing customer base.

"The acquisition of Magnex is strategic to advancing Varian, Inc.'s drive into magnetic resonance imaging. Magnex's expertise in the design of MR imaging will help Varian, since magnet technology is core to both MR imaging and high-resolution NMR. Having this capability further supports Varian's efforts to expand the use of these information-rich detectors,” stated Garry W. Rogerson, president and CEO, Varian.

The acquisition follows a successful five-year relationship, during which Magnex has been manufacturing state-of-the-art MRI magnet systems for Varian. It also builds on Magnex's supply to Varian of the Actively Shielded 800 mHz magnet. "This acquisition affords Magnex the opportunity to accelerate the development of cutting-edge magnet technology to grow our position in MR imaging magnets as well as to improve customer care and after-sales support through Varian, Inc.'s global sales and support infrastructure. We look forward to this exciting new phase in the history of Magnex and its continuing development within the Varian, Inc.'s family,” remarked David Rayner, managing director and a founder of Magnex.

Related Links:
Varian, Inc.
Magnex Scientific

Print article



view channel
Image: New Scenaria SE 64/128-slice Computed Tomography Scanner from Hitachi Medical Systems America (Photo courtesy of Business Wire).

Two new 64/128-Slice CT Scanners Cleared by the FDA

A major diagnostic imaging equipment provider has announced US FDA clearance of two new 64/128-slice Computed Tomography (CT) scanners. The Food and Drug Administration (FDA; Silver Spring, MD, USA)... Read more


view channel

Additional Aggressive Cancers Can Be Found Using Breast MRI Following Mammography Screening

The results of a study published online in the journal Radiology have shown that performing MRI scans, after the discovery of mammography breast cancer findings, sometimes shows larger and more aggressive tumors than those discovered in mammography. Breast Magnetic Resonance Imaging (MRI) is widely used for the screening... Read more


view channel

Fast, Noninvasive Assessment of Chronic Liver Disease Announced as Alternative to Biopsies

A leading ultrasound imaging vendor has presented the clinical benefits of its innovative technology for noninvasive assessment of the severity of liver fibrosis, at the Liver Meeting 2015, in San Francisco (CA, USA). Researchers have published more than 60 items on the reliability and effectiveness of the new technology.... Read more

Nuclear medicine

view channel
Image: Glioblastoma in a PET scanner with (left) and without (right) the YY146 marker (Photo courtesy of Weibo Cai, WISC).

Antibody Cancer Marker Causes Tumors to Light Up

A novel marker attaches to a molecule on highly aggressive brain cancer, resulting in glioblastoma tumor tissue being easily identified in a positron emission tomography (PET) scanner. Developed by... Read more

Imaging IT

view channel
Image: CTA images displayed in Google Glass (Photo courtesy of the Canadian Journal of Cardiology).

Virtual Reality Device Helps Treat Blocked Arteries

A wearable virtual reality (VR) device based on Google Glass can be used to guide revascularization of chronically blocked coronary arteries. Developed by researchers at the Institute of Cardiology... Read more

Industry News

view channel

Long-Term Strategic Managed Medical Equipment Services Partnership Announced

An 18-year strategic collaboration agreement, worth CAD 300 million, between a major medical imaging vendor and the Southwest York Region of Ontario in Canada, has been announced. The partnership is for managed equipment services to help advance medical technology in the Southwest York region, and to expand the accessibility... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.